| Trial name or title | Varenicline for adolescent smoking cessation |
| Methods | Double‐blind parallel‐group RCT |
| Participants | 166 adolescents aged 14 ‐ 21, daily smoker for 6+ months, motivated to quit and failed at least 1 quit attempt |
| Interventions | Varenicline vs placebo for 12 wks |
| Outcomes | Self‐reported CPD; CO‐validated smoking status at 26 wks; adverse events |
| Starting date | August 2012 |
| Contact information | Kevin M Gray |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.